2023-06-30 08:00
Annual report for the financial year 2022/2023 for Biovica International AB is published today on our website.
2023-06-21 08:00
Significant events during the first three quarters Significant events during the fourth quarter Significant events after the end of the period Webcast: When: 21 June 2023, 3 PM to 4 PM CET Where: registration via lyyti: https://www.lyyti.in/Q4_Earnings_Call...
2023-06-10 08:30
Biovica today announces that it has signed a provider contract with Contigo Health ConfigureNet™ provider network. This commercial agreement will make Biovica’s blood test, DiviTum® TKa, available to clients and their health plan members served by...
2023-06-01 16:02
Biovica, active in cancer diagnostics, today announces that a poster with DiviTum® TKa results from the SWOG study S0226 will be presented at the the world’s largest cancer conference, the annual ASCO meeting, on Sunday, June 4. The data supports the...
2023-05-17 21:00
Biovica today announces that Biovica Inc, the US laboratory and subsidiary of Biovica International AB, has signed a provider contract with MediNcrease Health Plans, a US, national provider network and provider advocacy firm, to make Biovica’s blood...
2023-05-17 14:15
The extra general meeting of Biovica International AB ("Biovica" or the "Company") was held today on 17 May 2023 and the following resolutions were passed by the meeting.
2023-04-27 14:30
The shareholders of Biovica International AB, reg. no. 556774-6150, (the "Company") are hereby invited to the extra general meeting to be held on Wednesday 17 May 2023, at 13.00 CET at Baker & McKenzie Advokatbyrå's premises at Vasagatan 7 in Stockholm...
2023-04-04 08:00
Biovica, active in cancer monitoring, today announces that the company has signed a commercial partnership agreement with the Italian company, IT Health Fusion, for the commercialization of the DiviTum® TKa assay in Italy.
2023-03-28 08:00
Biovica, active in cancer monitoring, today announces that the company has signed a commercial partnership with the European distributor TOROMEDICAL group for the commercialization of the DiviTumTKa test for clinical routine use in the Netherlands and...
2023-03-16 08:00
DiviTum® TKa ready for clinical use in the US
>4,500
Numbers of patients in studies
28
Publications
32
Pharma Projects